Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

33 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT02538965

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Children's Hospital Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Miller Children's Hospital Long Beach, California, United States

View all 62 locations

View Trial Details

Completed

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

NCT01392989

Conditions: Anemia, Bone Marrow Diseases, Bone Marrow Transplant Failure, +14 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

NCT00065143

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

NCT01602952

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +13 more
Locations: Local institution Mumbai, Maharashtra, India

Local institution Mumbai, Mazagaon, India

Local institution Daegu, Buk-gu, South Korea

Local institution Jeonju, Deokjin-gu, South Korea

View Trial Details

Completed

Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

NCT00611247

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

NCT01144793

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

NCT00025662

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Local Institution Jakarta, Indonesia

Local Institution Batangas, Philippines

Local Institution Manila, Philippines

Local Institution Busan, South Korea

View all 22 locations

View Trial Details

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

NCT00030186

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations: Not specified

View Trial Details

Completed

Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes

NCT00451997

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions